In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV vaccine, nirsevimab, or both, according to research published in the Sep. 26 ...
The increase correlated with an off-season surge in RSV, suggesting the infection may be associated with SUID rates. The research team emphasized that additional research is needed to better ...